Sorry, no results were found, search again?
3-6 June 2019
Oncostellae expands partnering activities for OST-122 at the 2019 BIO Int’l Convention in Philadelphia
10 Dec 2018
GI-restricted Jak3/Tyk2 inhibitor OST-122 well tolerated in clinical phase Ia study
23 Jul 2018
Oncostellae initiated clinical development of OST-122